Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2015-07-31, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CO/20150731/20-F/1/000.htm SEC Original: a15-6996_120f.htm
FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China

---

---

Webplus: CO/20150731/20-F/2_EX-8.1/000.htm SEC Original: a15-6996_1ex8d1.htm
List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem

---

---

Webplus: CO/20150731/20-F/3_EX-12.1/000.htm SEC Original: a15-6996_1ex12d1.htm
Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CO/20150731/20-F/4_EX-12.2/000.htm SEC Original: a15-6996_1ex12d2.htm
Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CO/20150731/20-F/5_EX-13.1/000.htm SEC Original: a15-6996_1ex13d1.htm
Certification CHINA CORD BLOOD CORPORATION July 31, 2015 Ting Zheng Chief Executive Officer July 31, 2015 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a15-6996_1ex13d1.htm EX-13.1

---

---

Webplus: CO/20150731/20-F/6_EX-15.1/000.htm SEC Original: a15-6996_1ex15d1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors China Cord Blood Corporation: Hong Kong, China July 31, 2015 EX-15.1 6 a15-6996_1ex15d1.htm EX-15.1

---

Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2015-07-31, XBRL Interactive FinancialsCIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER
CENTRAL HONG KONG, K3 000000